Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LYEL Lyell Immunopharma > Detailed Quotes

LYEL Lyell Immunopharma

Watchlist
3.340
+0.060+1.83%
Close  01/27 16:00 ET
3.480
+0.140+4.19%
Post Mkt Price 01/27 18:58 ET
High
3.392
Open
3.260
Turnover
1.79M
Low
3.220
Pre Close
3.280
Volume
539.19K
Market Cap
832.75M
P/E(TTM)
Loss
52wk High
8.740
Shares
249.33M
P/E(Static)
Loss
52wk Low
2.740
Float Cap
473.56M
Bid/Ask %
11.11%
Historical High
19.840
Shs Float
141.79M
Volume Ratio
0.64
Historical Low
2.740
Dividend TTM
--
Div Yield TTM
--
P/B
1.02
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.38%
Amplitude
5.23%
Avg Price
3.321
Lot Size
1
Float Cap
473.56M
Bid/Ask %
11.11%
Historical High
19.840
Shs Float
141.79M
Volume Ratio
0.64
Historical Low
2.740
Dividend TTM
--
P/B
1.02
Dividend LFY
--
Turnover Ratio
0.38%
Amplitude
5.23%
Avg Price
3.321
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
CEO: Dr. Lynn Seely,M.D.
Market: NASDAQ
Listing Date: 06/17/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist